Effects of dexmedetomidine nasal spray on perioperative anxiety and quality of postoperative recovery in patients undergoing modified radical mastectomy for breast cancer - Takeaways - MDSpire

Effects of dexmedetomidine nasal spray on perioperative anxiety and quality of postoperative recovery in patients undergoing modified radical mastectomy for breast cancer

  • By

  • Qi Han

  • Zichao Li

  • Hongyi Xiao

  • Fanceng Ji

  • Chunhui Zheng

  • Qinglan Li

  • June 15, 2026

  • 0 min

Share

  • 1

    Preoperative intranasal dexmedetomidine significantly reduced perioperative anxiety in breast cancer patients undergoing modified radical mastectomy.

  • 2

    Patients receiving dexmedetomidine had higher Quality of Recovery-15 scores at 24 and 48 hours post-surgery compared to the control group.

  • 3

    No significant differences were found in intraoperative hemodynamics, anesthetic consumption, or vasoactive drug use between the two groups.

  • 4

    Time to emergence from anesthesia was significantly longer in the dexmedetomidine group compared to the control group.

  • 5

    The study was a randomized, double-blind trial involving 90 female patients scheduled for modified radical mastectomy.

Original Source(s)

Related Content